The Comparison of The Efficacy and Safety of Original and Biosimilar Filgrastim in Prevention of Chemotherapy-Induced Neutropenia in Children with Cancer

Büyükavcı, Mustafa; Zuhal Keskin Yildirim

DSpace Home
→
Fakülteler / Faculties
→
Tıp Fakültesi
→
Dahili Tıp Bilimleri / Internal Medıcal Scıences
→
Makale Koleksiyonu
→
View Item

dc.contributor.authors	Buyukavci, M; Yildirim, ZK;
dc.date.accessioned	2020-02-27T08:28:33Z
dc.date.available	2020-02-27T08:28:33Z
dc.date.issued	2019
dc.identifier.citation	Buyukavci, M; Yildirim, ZK; (2019). The Comparison of The Efficacy and Safety of Original and Biosimilar Filgrastim in Prevention of Chemotherapy-Induced Neutropenia in Children with Cancer. EURASIAN JOURNAL OF MEDICINE, 51, 115-112
dc.identifier.issn	1308-8734
dc.identifier.uri	https://doi.org/10.5152/eurasianjmed.2018.18030
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66072
dc.description.abstract	Conclusion: The biosimilar filgrastim, Leucostim, is as effective and safe as the original drug for prophylaxis of chemotherapy-induced neutropenia in children.
dc.language	English
dc.publisher	AVES
dc.rights	info:eu-repo/semantics/openAccess
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.subject	General & Internal Medicine
dc.title	The Comparison of The Efficacy and Safety of Original and Biosimilar Filgrastim in Prevention of Chemotherapy-Induced Neutropenia in Children with Cancer
dc.type	Article
dc.identifier.volume	51
dc.identifier.startpage	112
dc.identifier.endpage	115
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Büyükavcı, Mustafa
dc.relation.journal	EURASIAN JOURNAL OF MEDICINE
dc.identifier.wos	WOS:000472088900003
dc.identifier.doi	10.5152/eurasianjmed.2018.18030
dc.identifier.eissn	1308-8742
dc.contributor.author	Büyükavcı, Mustafa
dc.contributor.author	Zuhal Keskin Yildirim